Chemotherapy for Metastatic Seminoma
Author Information
Author(s): J. Schuette, N. Niederle, M.E. Scheulen, S. Seeber, C.G. Schmidt
Primary Institution: Innere Universitdtsklinik und Poliklinik (Tumorforschung), Westdeutsches Tumorzentrum, Essen, FRG.
Hypothesis
The study investigates the efficacy and toxicity of different combination chemotherapies in treating advanced disseminated seminomas.
Conclusion
The study suggests a high probability of continuous complete remission in patients with bulky retroperitoneal and widespread metastatic seminoma.
Supporting Evidence
- 89% of patients achieved complete remission after treatment.
- 82% of patients are free of disease after a median follow-up of 28 months.
- Significant myelosuppression was observed in previously irradiated patients.
Takeaway
Doctors treated 28 men with a type of testicular cancer using different medicines, and most of them got better.
Methodology
Retrospective analysis of treatment response and survival in patients with metastatic seminoma.
Limitations
The study is retrospective and includes a limited number of patients.
Participant Demographics
Median age was 41 years, with a range of 23-52 years; 50% had elevated human chorionic gonadotropin levels.
Want to read the original?
Access the complete publication on the publisher's website